About this trial

Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.

Eligibility criteria

Qualifiers

above 18 years of age

willing to sign informed consent

have a rheumatoid condition

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 4 trial groups

Locations

1
Meir Medical Center Kfar Saba Israel

Sponsors and collaborators

Meir Medical Center

Lead sponsor